GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes
Tao Huang(Shandong University), Juan Jesús Carrero(Danderyds sjukhus), Edouard L. Fu(Leiden University Medical Center), Morgan E. Grams(New York University), Arvid Sjölander(Karolinska Institutet), Alessandro Bosi(Karolinska Institutet), Yang Xu(Peking University), Anne‐Laure Faucon(Karolinska Institutet)
Cited by 9
Related Papers
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|5.7k
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
|JAMA Internal Medicine|2016|719